Eye Diseases Completed Phase 2 Trials for Ocriplasmin (DB08888)

IndicationStatusPhase
DBCOND0030511 (Eye Diseases)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00123279Intravitreal Microplasmin in Patients Undergoing Surgical VitrectomyTreatment